{"gene":"DYNC1I2","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2010,"finding":"DYNC1I2 (Dync1i2) undergoes complex alternative splicing producing multiple isoforms with maximum complexity in the embryonic and adult nervous system; a new promoter and alternative non-coding exon 1 were identified for Dync1i2, indicating tissue-specific regulation of isoform expression relevant to cargo binding specificity.","method":"Systematic mRNA expression profiling across mouse tissues combined with bioinformatics analysis of mouse, rat, and human genomic/cDNA sequences; cloning of isoforms","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — systematic transcriptomic survey across multiple tissues with bioinformatics validation, single lab but multiple tissues and species","pmids":["20657784"],"is_preprint":false},{"year":1999,"finding":"DYNC1I2 (Dnci2) displays broad expression throughout the entire central nervous system and most of the peripheral nervous system during mouse embryogenesis, in contrast to the highly restricted Dnci1, indicating distinct functional roles for the two intermediate chain paralogs in neural development.","method":"RNA in situ hybridization during mouse embryogenesis","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment (in situ hybridization) across multiple developmental stages, single lab","pmids":["10049579"],"is_preprint":false},{"year":2013,"finding":"ERK phosphorylates DYNC1I2 (IC-2) on a novel, highly conserved serine residue proximal to the binding site for the p150Glued subunit of the dynactin cargo adapter, following EGF receptor stimulation of fibroblasts. Neither constitutive phosphorylation nor a phosphomimetic substitution of this serine influences binding of p150Glued to IC-2, indicating ERK phosphorylation regulates dynein function through mechanisms other than dynactin interaction.","method":"Affinity purification, in vitro kinase assay with ERK, site identification by mass spectrometry, site-directed mutagenesis (phosphomimetic substitution), co-immunoprecipitation of p150Glued","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — affinity purification identification, in vitro kinase assay, site-directed mutagenesis, and binding assay in a single study with multiple orthogonal methods","pmids":["23434660"],"is_preprint":false},{"year":2019,"finding":"Loss-of-function variants in DYNC1I2 cause autosomal-recessive syndromic microcephaly with cerebral malformations. In zebrafish, CRISPR-Cas9 disruption or transient suppression of dync1i2a caused craniofacial patterning defects, reduced head size, increased apoptosis, and abnormal mitotic spindle morphology leading to prolonged mitosis. Complementation studies confirmed that the p.Tyr247Cys variant attenuates gene function.","method":"Whole-exome sequencing in human patients; CRISPR-Cas9 gene disruption and morpholino knockdown in zebrafish; cell death and cell cycle progression analysis; spindle morphology imaging; complementation assay with patient variant","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined cellular phenotype (spindle abnormality, apoptosis), complementation with patient variant, replicated across multiple genetic models and independent pedigrees","pmids":["31079899"],"is_preprint":false},{"year":2021,"finding":"TMEM39A (TMEM-39 in C. elegans) interacts with DYNC1I2 to maintain proper perinuclear lysosome distribution. Loss of TMEM39A in mammalian cells redistributes lysosomes from the perinuclear region to the cell periphery, phenocopying loss of the DYNC1I2 homolog, and both deficiencies impair mTOR signaling and activate the TFEB-like transcription factor HLH-30.","method":"Co-immunoprecipitation (TMEM39A–DYNC1I2 interaction); genetic knockouts in C. elegans and mammalian cells; lysosome distribution imaging; mTOR signaling assays; HLH-30/TFEB reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction by Co-IP, genetic knockouts in two organisms, lysosome distribution phenotype, downstream signaling readout; multiple orthogonal methods","pmids":["33531362"],"is_preprint":false},{"year":2022,"finding":"The primate-specific lncRNA HHIP-AS1 binds directly to the mRNA of DYNC1I2 and attenuates its degradation by hsa-miR-425-5p, thereby stabilizing DYNC1I2 protein levels. Knockdown of HHIP-AS1 induces mitotic spindle deregulation impairing tumorigenicity in vitro and in vivo. Neither HHIP-AS1 nor the corresponding regulatory element in DYNC1I2 are conserved in mice.","method":"RNA pulldown/direct binding assay (lncRNA–mRNA), miRNA functional assays, HHIP-AS1 knockdown with mitotic spindle imaging and in vivo tumorigenicity assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct RNA–RNA binding demonstrated, miRNA degradation mechanism, in vitro and in vivo phenotypic validation; single lab but multiple methods; findings concern a non-coding RNA's regulation of DYNC1I2 mRNA rather than DYNC1I2 protein mechanism per se","pmids":["35831316"],"is_preprint":false},{"year":2026,"finding":"In a rat diabetic peripheral neuropathy model treated with alpha-lipoic acid (ALA), DYNC1I2 protein expression in sciatic nerve was downregulated by ALA, concomitant with upregulation of the anterograde motor KIF5A, suggesting DYNC1I2-mediated retrograde mitochondrial axonal transport is modulated by ALA via AMPK/CREB signaling.","method":"Western blotting and immunofluorescence in rat sciatic nerve and NSC34 cells (high glucose/palmitate model); pharmacological treatment with ALA; AMPK/CREB pathway analysis","journal":"PloS one","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Western blot and immunofluorescence in a pharmacological model, single lab, no direct mechanistic dissection of DYNC1I2 function","pmids":["41920893"],"is_preprint":false}],"current_model":"DYNC1I2 encodes the cytoplasmic dynein-1 intermediate chain 2, a subunit critical for cargo-specific minus-end-directed microtubule transport; it is expressed broadly in the nervous system via alternatively spliced isoforms, is phosphorylated by ERK on a conserved serine near the dynactin-p150Glued binding site (affecting dynein function through a mechanism independent of dynactin binding), interacts with TMEM39A to maintain perinuclear lysosome positioning and support mTOR signaling, is post-transcriptionally stabilized in human SHH-driven tumors by the lncRNA HHIP-AS1 (which shields its mRNA from miR-425-5p), and is required for proper mitotic spindle assembly and neurogenesis—as shown by the finding that bi-allelic loss-of-function variants in humans and zebrafish cause microcephaly via increased apoptosis attributable to prolonged mitosis from spindle abnormalities."},"narrative":{"mechanistic_narrative":"DYNC1I2 encodes an intermediate chain of the cytoplasmic dynein-1 motor complex that drives minus-end-directed microtubule transport and is required for proper mitotic spindle assembly and neurodevelopment [PMID:31079899]. During embryogenesis it is broadly expressed throughout the central and peripheral nervous system, in contrast to the more restricted paralog, and produces multiple alternatively spliced isoforms whose complexity peaks in neural tissue, consistent with tissue-specific tuning of cargo-binding specificity [PMID:10049579, PMID:20657784]. Its motor function is regulated by ERK, which phosphorylates a conserved serine near the binding site for the dynactin subunit p150Glued following EGF receptor stimulation; this modification does not alter p150Glued binding, indicating regulation of dynein activity through a dynactin-independent route [PMID:23434660]. DYNC1I2 also supports organelle positioning: it interacts with TMEM39A to maintain perinuclear lysosome distribution, and loss of either protein disperses lysosomes to the cell periphery, impairs mTOR signaling, and activates the TFEB-like factor HLH-30 [PMID:33531362]. Bi-allelic loss-of-function variants in humans cause autosomal-recessive syndromic microcephaly with cerebral malformations, and disruption in zebrafish reproduces reduced head size, abnormal mitotic spindle morphology, prolonged mitosis, and increased apoptosis, establishing that spindle defects underlie the neurodevelopmental phenotype [PMID:31079899].","teleology":[{"year":1999,"claim":"Establishing where the two dynein intermediate-chain paralogs act resolved whether they are redundant: DYNC1I2 shows broad nervous-system expression unlike the restricted paralog, implying distinct developmental roles.","evidence":"RNA in situ hybridization across mouse embryogenesis","pmids":["10049579"],"confidence":"Medium","gaps":["Expression pattern alone does not define a molecular function","Functional non-redundancy with the paralog not directly tested"]},{"year":2010,"claim":"Mapping the isoform repertoire addressed how cargo-binding diversity might be generated: DYNC1I2 undergoes complex alternative splicing with maximal complexity in nervous tissue, plus a novel promoter and non-coding exon 1.","evidence":"mRNA expression profiling across mouse tissues with cross-species bioinformatics and isoform cloning","pmids":["20657784"],"confidence":"Medium","gaps":["Functional consequences of specific isoforms on cargo selection not demonstrated","Promoter usage not linked to a phenotype"]},{"year":2013,"claim":"Identifying an ERK phosphosite addressed how signaling regulates the motor: a conserved serine near the p150Glued binding site is phosphorylated after EGF stimulation, but does not change dynactin binding, implying a dynactin-independent regulatory mechanism.","evidence":"Affinity purification, in vitro ERK kinase assay, mass spectrometry site mapping, phosphomimetic mutagenesis, and p150Glued co-immunoprecipitation in fibroblasts","pmids":["23434660"],"confidence":"High","gaps":["The actual dynactin-independent effect of phosphorylation on dynein function not identified","In vivo relevance of the phosphosite not established"]},{"year":2019,"claim":"Linking DYNC1I2 to human disease established its essential developmental role: bi-allelic loss-of-function causes syndromic microcephaly, and animal models traced this to spindle abnormality, prolonged mitosis, and apoptosis.","evidence":"Whole-exome sequencing of patients; CRISPR-Cas9 and morpholino disruption in zebrafish with cell-death, cell-cycle, and spindle imaging; patient-variant complementation","pmids":["31079899"],"confidence":"High","gaps":["Molecular mechanism connecting dynein intermediate chain loss to spindle defect not dissected","Cargo specificity in neural progenitors not defined"]},{"year":2021,"claim":"Defining a partner for organelle positioning extended DYNC1I2 function beyond mitosis: it interacts with TMEM39A to maintain perinuclear lysosomes and support mTOR signaling.","evidence":"Co-immunoprecipitation; C. elegans and mammalian knockouts; lysosome distribution imaging; mTOR and HLH-30/TFEB reporter assays","pmids":["33531362"],"confidence":"High","gaps":["How TMEM39A couples to the dynein motor mechanistically not resolved","Whether lysosome mispositioning contributes to the microcephaly phenotype unknown"]},{"year":2022,"claim":"Uncovering post-transcriptional control showed DYNC1I2 levels are actively buffered: the primate-specific lncRNA HHIP-AS1 binds its mRNA and shields it from miR-425-5p degradation, stabilizing protein in SHH-driven tumors.","evidence":"RNA pulldown/direct binding assay, miRNA functional assays, HHIP-AS1 knockdown with spindle imaging and in vivo tumorigenicity assays","pmids":["35831316"],"confidence":"Medium","gaps":["This concerns regulation of DYNC1I2 mRNA, not the protein's own mechanism","Regulatory element not conserved in mice, limiting generalizability"]},{"year":2026,"claim":"A pharmacological neuropathy model placed DYNC1I2 in axonal mitochondrial transport: alpha-lipoic acid downregulates DYNC1I2 while upregulating the anterograde motor KIF5A via AMPK/CREB signaling.","evidence":"Western blotting and immunofluorescence in rat sciatic nerve and NSC34 cells under high glucose/palmitate with ALA treatment and AMPK/CREB pathway analysis","pmids":["41920893"],"confidence":"Low","gaps":["No direct mechanistic dissection of DYNC1I2 in transport — correlation only","Causal role of DYNC1I2 changes in the neuropathy phenotype not tested"]},{"year":null,"claim":"How DYNC1I2 isoform identity and ERK phosphorylation select specific cargoes, and how the spindle-assembly defect mechanistically produces microcephaly, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of how phosphorylation alters dynein function independent of dynactin","Cargo-specific isoform functions not mapped","Mechanistic link between spindle abnormality and neural progenitor apoptosis not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[4]}],"complexes":["cytoplasmic dynein-1"],"partners":["DCTN1","TMEM39A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13409","full_name":"Cytoplasmic dynein 1 intermediate chain 2","aliases":["Cytoplasmic dynein intermediate chain 2","Dynein intermediate chain 2, cytosolic","DH IC-2"],"length_aa":638,"mass_kda":71.5,"function":"Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function (PubMed:31079899). Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules (PubMed:31079899). The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150-glued) DCTN1 (By similarity). Involved in membrane-transport, such as Golgi apparatus, late endosomes and lysosomes (By similarity)","subcellular_location":"Cytoplasm, cytoskeleton; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q13409/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/DYNC1I2","classification":"Common Essential","n_dependent_lines":1198,"n_total_lines":1208,"dependency_fraction":0.9917218543046358},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000077380","cell_line_id":"CID001406","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"cytoskeleton","grade":3},{"compartment":"centrosome","grade":2}],"interactors":[{"gene":"DYNC1H1","stoichiometry":10.0},{"gene":"PAFAH1B1","stoichiometry":10.0},{"gene":"DYNLT3","stoichiometry":10.0},{"gene":"DYNLRB1","stoichiometry":10.0},{"gene":"DYNC1LI1","stoichiometry":10.0},{"gene":"DCTN2","stoichiometry":10.0},{"gene":"DYNLT1","stoichiometry":10.0},{"gene":"CLIP1","stoichiometry":4.0},{"gene":"DCTN3","stoichiometry":4.0},{"gene":"DYNC1LI2","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001406","total_profiled":1310},"omim":[{"mim_id":"621550","title":"TRANSMEMBRANE PROTEIN 39A; TMEM39A","url":"https://www.omim.org/entry/621550"},{"mim_id":"618492","title":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA","url":"https://www.omim.org/entry/618492"},{"mim_id":"617786","title":"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 8; CCT8","url":"https://www.omim.org/entry/617786"},{"mim_id":"610172","title":"SPERM FLAGELLAR PROTEIN 2; SPEF2","url":"https://www.omim.org/entry/610172"},{"mim_id":"603331","title":"DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2; DYNC1I2","url":"https://www.omim.org/entry/603331"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Microtubules","reliability":"Approved"},{"location":"Centrosome","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Flagellar centriole","reliability":"Approved"},{"location":"Mid piece","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"End piece","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DYNC1I2"},"hgnc":{"alias_symbol":["DIC74"],"prev_symbol":["DNCI2"]},"alphafold":{"accession":"Q13409","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13409","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13409-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13409-F1-predicted_aligned_error_v6.png","plddt_mean":72.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DYNC1I2","jax_strain_url":"https://www.jax.org/strain/search?query=DYNC1I2"},"sequence":{"accession":"Q13409","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13409.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13409/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13409"}},"corpus_meta":[{"pmid":"15520179","id":"PMC_15520179","title":"From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15520179","citation_count":72,"is_preprint":false},{"pmid":"20657784","id":"PMC_20657784","title":"Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20657784","citation_count":35,"is_preprint":false},{"pmid":"10049579","id":"PMC_10049579","title":"Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10049579","citation_count":34,"is_preprint":false},{"pmid":"35831316","id":"PMC_35831316","title":"The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831316","citation_count":26,"is_preprint":false},{"pmid":"31079899","id":"PMC_31079899","title":"Bi-allelic Variants in DYNC1I2 Cause Syndromic Microcephaly with Intellectual Disability, Cerebral Malformations, and Dysmorphic Facial Features.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31079899","citation_count":24,"is_preprint":false},{"pmid":"25101965","id":"PMC_25101965","title":"Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.","date":"2014","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25101965","citation_count":24,"is_preprint":false},{"pmid":"33531362","id":"PMC_33531362","title":"The conserved autoimmune-disease risk gene TMEM39A regulates lysosome dynamics.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33531362","citation_count":8,"is_preprint":false},{"pmid":"23434660","id":"PMC_23434660","title":"Epidermal growth factor stimulates extracellular-signal regulated kinase phosphorylation of a novel site on cytoplasmic Dynein intermediate chain 2.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23434660","citation_count":7,"is_preprint":false},{"pmid":"34740731","id":"PMC_34740731","title":"Copy number variation of bovine DYNC1I2 gene is associated with body conformation traits in chinese beef cattle.","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34740731","citation_count":6,"is_preprint":false},{"pmid":"37239413","id":"PMC_37239413","title":"Single-Locus and Multi-Locus Genome-Wide Association Studies Identify Genes Associated with Liver Cu Concentration in Merinoland Sheep.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37239413","citation_count":4,"is_preprint":false},{"pmid":"38293699","id":"PMC_38293699","title":"Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study.","date":"2024","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38293699","citation_count":3,"is_preprint":false},{"pmid":"41920893","id":"PMC_41920893","title":"Effect of ALA on preventing diabetic peripheral neuropathy in rats through mitochondrial axonal transport.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41920893","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8468,"output_tokens":2156,"usd":0.028872,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9206,"output_tokens":2794,"usd":0.05794,"stage2_stop_reason":"end_turn"},"total_usd":0.086812,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"DYNC1I2 (Dync1i2) undergoes complex alternative splicing producing multiple isoforms with maximum complexity in the embryonic and adult nervous system; a new promoter and alternative non-coding exon 1 were identified for Dync1i2, indicating tissue-specific regulation of isoform expression relevant to cargo binding specificity.\",\n      \"method\": \"Systematic mRNA expression profiling across mouse tissues combined with bioinformatics analysis of mouse, rat, and human genomic/cDNA sequences; cloning of isoforms\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — systematic transcriptomic survey across multiple tissues with bioinformatics validation, single lab but multiple tissues and species\",\n      \"pmids\": [\"20657784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DYNC1I2 (Dnci2) displays broad expression throughout the entire central nervous system and most of the peripheral nervous system during mouse embryogenesis, in contrast to the highly restricted Dnci1, indicating distinct functional roles for the two intermediate chain paralogs in neural development.\",\n      \"method\": \"RNA in situ hybridization during mouse embryogenesis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment (in situ hybridization) across multiple developmental stages, single lab\",\n      \"pmids\": [\"10049579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ERK phosphorylates DYNC1I2 (IC-2) on a novel, highly conserved serine residue proximal to the binding site for the p150Glued subunit of the dynactin cargo adapter, following EGF receptor stimulation of fibroblasts. Neither constitutive phosphorylation nor a phosphomimetic substitution of this serine influences binding of p150Glued to IC-2, indicating ERK phosphorylation regulates dynein function through mechanisms other than dynactin interaction.\",\n      \"method\": \"Affinity purification, in vitro kinase assay with ERK, site identification by mass spectrometry, site-directed mutagenesis (phosphomimetic substitution), co-immunoprecipitation of p150Glued\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — affinity purification identification, in vitro kinase assay, site-directed mutagenesis, and binding assay in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"23434660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Loss-of-function variants in DYNC1I2 cause autosomal-recessive syndromic microcephaly with cerebral malformations. In zebrafish, CRISPR-Cas9 disruption or transient suppression of dync1i2a caused craniofacial patterning defects, reduced head size, increased apoptosis, and abnormal mitotic spindle morphology leading to prolonged mitosis. Complementation studies confirmed that the p.Tyr247Cys variant attenuates gene function.\",\n      \"method\": \"Whole-exome sequencing in human patients; CRISPR-Cas9 gene disruption and morpholino knockdown in zebrafish; cell death and cell cycle progression analysis; spindle morphology imaging; complementation assay with patient variant\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined cellular phenotype (spindle abnormality, apoptosis), complementation with patient variant, replicated across multiple genetic models and independent pedigrees\",\n      \"pmids\": [\"31079899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TMEM39A (TMEM-39 in C. elegans) interacts with DYNC1I2 to maintain proper perinuclear lysosome distribution. Loss of TMEM39A in mammalian cells redistributes lysosomes from the perinuclear region to the cell periphery, phenocopying loss of the DYNC1I2 homolog, and both deficiencies impair mTOR signaling and activate the TFEB-like transcription factor HLH-30.\",\n      \"method\": \"Co-immunoprecipitation (TMEM39A–DYNC1I2 interaction); genetic knockouts in C. elegans and mammalian cells; lysosome distribution imaging; mTOR signaling assays; HLH-30/TFEB reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction by Co-IP, genetic knockouts in two organisms, lysosome distribution phenotype, downstream signaling readout; multiple orthogonal methods\",\n      \"pmids\": [\"33531362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The primate-specific lncRNA HHIP-AS1 binds directly to the mRNA of DYNC1I2 and attenuates its degradation by hsa-miR-425-5p, thereby stabilizing DYNC1I2 protein levels. Knockdown of HHIP-AS1 induces mitotic spindle deregulation impairing tumorigenicity in vitro and in vivo. Neither HHIP-AS1 nor the corresponding regulatory element in DYNC1I2 are conserved in mice.\",\n      \"method\": \"RNA pulldown/direct binding assay (lncRNA–mRNA), miRNA functional assays, HHIP-AS1 knockdown with mitotic spindle imaging and in vivo tumorigenicity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct RNA–RNA binding demonstrated, miRNA degradation mechanism, in vitro and in vivo phenotypic validation; single lab but multiple methods; findings concern a non-coding RNA's regulation of DYNC1I2 mRNA rather than DYNC1I2 protein mechanism per se\",\n      \"pmids\": [\"35831316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In a rat diabetic peripheral neuropathy model treated with alpha-lipoic acid (ALA), DYNC1I2 protein expression in sciatic nerve was downregulated by ALA, concomitant with upregulation of the anterograde motor KIF5A, suggesting DYNC1I2-mediated retrograde mitochondrial axonal transport is modulated by ALA via AMPK/CREB signaling.\",\n      \"method\": \"Western blotting and immunofluorescence in rat sciatic nerve and NSC34 cells (high glucose/palmitate model); pharmacological treatment with ALA; AMPK/CREB pathway analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Western blot and immunofluorescence in a pharmacological model, single lab, no direct mechanistic dissection of DYNC1I2 function\",\n      \"pmids\": [\"41920893\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DYNC1I2 encodes the cytoplasmic dynein-1 intermediate chain 2, a subunit critical for cargo-specific minus-end-directed microtubule transport; it is expressed broadly in the nervous system via alternatively spliced isoforms, is phosphorylated by ERK on a conserved serine near the dynactin-p150Glued binding site (affecting dynein function through a mechanism independent of dynactin binding), interacts with TMEM39A to maintain perinuclear lysosome positioning and support mTOR signaling, is post-transcriptionally stabilized in human SHH-driven tumors by the lncRNA HHIP-AS1 (which shields its mRNA from miR-425-5p), and is required for proper mitotic spindle assembly and neurogenesis—as shown by the finding that bi-allelic loss-of-function variants in humans and zebrafish cause microcephaly via increased apoptosis attributable to prolonged mitosis from spindle abnormalities.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DYNC1I2 encodes an intermediate chain of the cytoplasmic dynein-1 motor complex that drives minus-end-directed microtubule transport and is required for proper mitotic spindle assembly and neurodevelopment [#3]. During embryogenesis it is broadly expressed throughout the central and peripheral nervous system, in contrast to the more restricted paralog, and produces multiple alternatively spliced isoforms whose complexity peaks in neural tissue, consistent with tissue-specific tuning of cargo-binding specificity [#1, #0]. Its motor function is regulated by ERK, which phosphorylates a conserved serine near the binding site for the dynactin subunit p150Glued following EGF receptor stimulation; this modification does not alter p150Glued binding, indicating regulation of dynein activity through a dynactin-independent route [#2]. DYNC1I2 also supports organelle positioning: it interacts with TMEM39A to maintain perinuclear lysosome distribution, and loss of either protein disperses lysosomes to the cell periphery, impairs mTOR signaling, and activates the TFEB-like factor HLH-30 [#4]. Bi-allelic loss-of-function variants in humans cause autosomal-recessive syndromic microcephaly with cerebral malformations, and disruption in zebrafish reproduces reduced head size, abnormal mitotic spindle morphology, prolonged mitosis, and increased apoptosis, establishing that spindle defects underlie the neurodevelopmental phenotype [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing where the two dynein intermediate-chain paralogs act resolved whether they are redundant: DYNC1I2 shows broad nervous-system expression unlike the restricted paralog, implying distinct developmental roles.\",\n      \"evidence\": \"RNA in situ hybridization across mouse embryogenesis\",\n      \"pmids\": [\"10049579\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Expression pattern alone does not define a molecular function\", \"Functional non-redundancy with the paralog not directly tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapping the isoform repertoire addressed how cargo-binding diversity might be generated: DYNC1I2 undergoes complex alternative splicing with maximal complexity in nervous tissue, plus a novel promoter and non-coding exon 1.\",\n      \"evidence\": \"mRNA expression profiling across mouse tissues with cross-species bioinformatics and isoform cloning\",\n      \"pmids\": [\"20657784\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequences of specific isoforms on cargo selection not demonstrated\", \"Promoter usage not linked to a phenotype\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying an ERK phosphosite addressed how signaling regulates the motor: a conserved serine near the p150Glued binding site is phosphorylated after EGF stimulation, but does not change dynactin binding, implying a dynactin-independent regulatory mechanism.\",\n      \"evidence\": \"Affinity purification, in vitro ERK kinase assay, mass spectrometry site mapping, phosphomimetic mutagenesis, and p150Glued co-immunoprecipitation in fibroblasts\",\n      \"pmids\": [\"23434660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The actual dynactin-independent effect of phosphorylation on dynein function not identified\", \"In vivo relevance of the phosphosite not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking DYNC1I2 to human disease established its essential developmental role: bi-allelic loss-of-function causes syndromic microcephaly, and animal models traced this to spindle abnormality, prolonged mitosis, and apoptosis.\",\n      \"evidence\": \"Whole-exome sequencing of patients; CRISPR-Cas9 and morpholino disruption in zebrafish with cell-death, cell-cycle, and spindle imaging; patient-variant complementation\",\n      \"pmids\": [\"31079899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism connecting dynein intermediate chain loss to spindle defect not dissected\", \"Cargo specificity in neural progenitors not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defining a partner for organelle positioning extended DYNC1I2 function beyond mitosis: it interacts with TMEM39A to maintain perinuclear lysosomes and support mTOR signaling.\",\n      \"evidence\": \"Co-immunoprecipitation; C. elegans and mammalian knockouts; lysosome distribution imaging; mTOR and HLH-30/TFEB reporter assays\",\n      \"pmids\": [\"33531362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TMEM39A couples to the dynein motor mechanistically not resolved\", \"Whether lysosome mispositioning contributes to the microcephaly phenotype unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncovering post-transcriptional control showed DYNC1I2 levels are actively buffered: the primate-specific lncRNA HHIP-AS1 binds its mRNA and shields it from miR-425-5p degradation, stabilizing protein in SHH-driven tumors.\",\n      \"evidence\": \"RNA pulldown/direct binding assay, miRNA functional assays, HHIP-AS1 knockdown with spindle imaging and in vivo tumorigenicity assays\",\n      \"pmids\": [\"35831316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"This concerns regulation of DYNC1I2 mRNA, not the protein's own mechanism\", \"Regulatory element not conserved in mice, limiting generalizability\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A pharmacological neuropathy model placed DYNC1I2 in axonal mitochondrial transport: alpha-lipoic acid downregulates DYNC1I2 while upregulating the anterograde motor KIF5A via AMPK/CREB signaling.\",\n      \"evidence\": \"Western blotting and immunofluorescence in rat sciatic nerve and NSC34 cells under high glucose/palmitate with ALA treatment and AMPK/CREB pathway analysis\",\n      \"pmids\": [\"41920893\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct mechanistic dissection of DYNC1I2 in transport — correlation only\", \"Causal role of DYNC1I2 changes in the neuropathy phenotype not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DYNC1I2 isoform identity and ERK phosphorylation select specific cargoes, and how the spindle-assembly defect mechanistically produces microcephaly, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of how phosphorylation alters dynein function independent of dynactin\", \"Cargo-specific isoform functions not mapped\", \"Mechanistic link between spindle abnormality and neural progenitor apoptosis not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\"cytoplasmic dynein-1\"],\n    \"partners\": [\"DCTN1\", \"TMEM39A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}